InvestorsHub Logo
Followers 3
Posts 147
Boards Moderated 0
Alias Born 06/23/2017

Re: Polyphemus post# 9682

Wednesday, 06/17/2020 6:44:02 PM

Wednesday, June 17, 2020 6:44:02 PM

Post# of 10350
Hey....I will take my lumps when they are due.
I had 3 million shares and have dumped them all.
Great product - terrible management.

The money was never in the external product.
It was always in the internal product for surgery.
Which is unique.

Norchi had some curveballs thrown his way and always struck out.

Plan A was to get the external approved and then a licensing deal to pay for the internal process.
Great plan. But unfortunately Plan A doesn't always work out.

So you need to go to Plan B. And he never did.

There were 2 big mistakes.

First - when they filed the CE application years ago as a drug and not a medical device. And it was rejected........

Well they shouldn't have said.."Well we will move on to something else."

They should have spent 6 weeks re-doing the application.
Then........
It either gets accepted or rejected.

If it gets approved.....Well great.
If it doesn't....well at least they would know why.
And the stuff could have been fixed years ago.

Second - after FDA approval 18 months ago......
Well. When 6 months went by with no licensing deal.
They should have just bitten the bullet. And diluted.
The internal trials could be done by now.
and the FDA and CE applications submitted and under review.

Instead.....
At some point next year they will start the internal trials.
And it could be 2 years before everything is done and approved.
With possibly 800 million shares outstanding...
If they can get new investors.

I don't buy the conspiracy they have intentionally dogged it.
And just exist to collect a salary.

It is a great product.
But it was always the internal product that had the value.

And Management was never able to move from Plan A to Plan B.
Or maybe even Plan C.

And that is what you need to be able to do to take a penny stock across the finish line.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ARTH News